Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)

NCT00562406 is registered in ClinicalTrials.gov with Klinikum Ludwigshafen as lead sponsor.

NCT NCT00562406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
Lead sponsor
Klinikum Ludwigshafen
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
September 30, 2010
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema